Chanvorachote Pithi, Chunhacha Preedakorn, Pongrakhananon Varisa
Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences and Cell-based Drug and Health Product Development Research Unit, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.
Cancer Cell Int. 2014 Jun 14;14:52. doi: 10.1186/1475-2867-14-52. eCollection 2014.
The enhancement of migration is critical for facilitating cancer cell metastasis.
Lung cancer H23 cells were transfected with either a caveolin-1 (Cav-1) overexpression or shCav-1 plasmid and further subjected to cell migration assays and lamellipodia characterization. The regulation of Cav-1 via an ATP-dependent tyrosine kinase (Akt) pathway was further examined by Akt knockdown in Cav-1 overexpressing cells and migratory behavior investigations.
Here, we demonstrate for the first time that overexpression of Cav-1 in human lung cancer H23 cells significantly increased the formation of lamellipodia, whereas the suppression of Cav-1 using shRNA transfection had the opposite effect. Consistent with an increase in lamellipodia, Cav-1 overexpressing cells exhibited increased migratory activity in comparison to their parental, control-transfected, H23 cells. The induction of lamellipodia was demonstrated to occur via the Akt pathway because the addition of the Akt inhibitor LY294002 inhibited lamellipodia in both Cav-1-overexpressing and H23 cells. Additionally, transient transfection with Akt-siRNA significantly inhibited the formation of lamellipodia and the migration of Cav-1-overexpressing H23 cells. In addition, Cav-1 levels and the migratory action of other lung cancer cells, namely, H460 and A549, were assessed, and the migration of these cells was found to be correlated with the basal Cav-1 level.
These data showed that Cav-1 enhances cancer cell migration through Akt-mediated lamellipodia formation. Our results provide novel insights regarding the molecular mechanism controlling cancer cell migration, leading to a better understanding of cancer cell biology.
迁移能力的增强对于促进癌细胞转移至关重要。
用小窝蛋白-1(Cav-1)过表达质粒或shCav-1质粒转染肺癌H23细胞,然后进行细胞迁移试验和板状伪足特征分析。通过在Cav-1过表达细胞中敲低Akt并进行迁移行为研究,进一步检测Akt途径对Cav-1的调控作用。
在此,我们首次证明,人肺癌H23细胞中Cav-1的过表达显著增加了板状伪足的形成,而使用shRNA转染抑制Cav-1则产生相反的效果。与板状伪足增加一致,与亲本对照转染的H23细胞相比,Cav-1过表达细胞表现出更高的迁移活性。已证明板状伪足的诱导是通过Akt途径发生的,因为添加Akt抑制剂LY294002可抑制Cav-1过表达细胞和H23细胞中的板状伪足形成。此外,用Akt-siRNA瞬时转染可显著抑制Cav-1过表达的H23细胞中板状伪足的形成和迁移。另外,评估了其他肺癌细胞(即H460和A549)的Cav-1水平和迁移作用,发现这些细胞中的迁移与基础Cav-1水平相关。
这些数据表明,Cav-1通过Akt介导的板状伪足形成增强癌细胞迁移。我们的结果为控制癌细胞迁移的分子机制提供了新的见解,有助于更好地理解癌细胞生物学。